NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

Search

Coloplast A-S (Class B)

Abrir

437 -2.13

Visão Geral

Variação de preço das ações

24h

Atual

Mín

435.8

Máximo

446.5

Indicadores-chave

By Trading Economics

Rendimento

522M

1.4B

Vendas

83M

7B

P/E

Médio do Setor

24.148

63.808

EPS

6.32

Rendimento de Dividendos

5.41

Margem de lucro

19.835

Funcionários

16,983

EBITDA

309M

2.3B

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+11.86% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

5.41%

2.38%

Próximos Ganhos

12 de mai. de 2026

Próxima data de dividendos

20 de mai. de 2026

Próxima data de ex-dividendo

18 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-22B

96B

Abertura anterior

439.13

Fecho anterior

437

Coloplast A-S (Class B) Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

19 de abr. de 2026, 23:48 UTC

Notícias Principais

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 de abr. de 2026, 23:36 UTC

Notícias Principais

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 de abr. de 2026, 22:47 UTC

Notícias Principais

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 de abr. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 de abr. de 2026, 23:49 UTC

Conversa de Mercado
Notícias Principais

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 de abr. de 2026, 23:46 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 de abr. de 2026, 23:38 UTC

Notícias Principais

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 de abr. de 2026, 23:36 UTC

Conversa de Mercado
Notícias Principais

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 de abr. de 2026, 23:12 UTC

Notícias Principais

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 de abr. de 2026, 23:10 UTC

Notícias Principais

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 de abr. de 2026, 23:09 UTC

Notícias Principais

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 de abr. de 2026, 23:08 UTC

Notícias Principais

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 de abr. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 de abr. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 de abr. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 de abr. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 de abr. de 2026, 20:03 UTC

Notícias Principais

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 de abr. de 2026, 20:03 UTC

Notícias Principais

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 de abr. de 2026, 20:03 UTC

Notícias Principais

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 de abr. de 2026, 20:03 UTC

Notícias Principais

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 de abr. de 2026, 01:00 UTC

Notícias Principais

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 de abr. de 2026, 22:58 UTC

Ganhos

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 de abr. de 2026, 21:32 UTC

Conversa de Mercado

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 de abr. de 2026, 21:22 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

17 de abr. de 2026, 21:22 UTC

Conversa de Mercado

Moody's Downgrades Belgium to A1 -- Market Talk

17 de abr. de 2026, 20:52 UTC

Ganhos

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 de abr. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

17 de abr. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

17 de abr. de 2026, 20:29 UTC

Ganhos

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Comparação entre Pares

Variação de preço

Coloplast A-S (Class B) Previsão

Preço-alvo

By TipRanks

11.86% parte superior

Previsão para 12 meses

Média 901.38 DKK  11.86%

Máximo 1,056 DKK

Mínimo 720 DKK

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para Coloplast A-S (Class B) - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

8 ratings

2

Comprar

4

Manter

2

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat